Home › NDC Lookup › Ingredients › Glycerin › 59779-0109-50
CVS Pharmacy Glycerin Laxative 2 g Suppository, 50 suppositories — NDC 59779-0109-50 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

CVS Pharmacy Glycerin Laxative 2 g Suppository, 50 suppositories — NDC 59779-109-50 (Billing 59779-0109-50)

by CVS Pharmacy · 50 SUPPOSITORY in 1 JAR

This is a package of 50 suppositories of CVS Pharmacy Glycerin Laxative 2 g Suppository from CVS Pharmacy, marketed since Sep 2014 and currently FDA-listed.

NDC 59779-0109-50
🏷️ FDA NDC (as labeled) 59779-109-50 billing pads the product segment with a zero
This package
Contains50 suppositories Pack sizes3 compare ↓
Product page 59779-0109-00 Also comes in: 25 suppositories 59779-109-25 100 suppositories 59779-109-00
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 59779-109-50 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
59779 labeler · 109 product · 50 package
Listing certified through
Dec 31, 2027
Barcode (UPC)
0050428619445
FDA record last changed
Oct 8, 2026
⚠️
Other active recalls for Glycerin (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 27, 2026 — Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. (Oasis Medical, Inc.) · FDA recall D-0525-2026
Class II · Apr 20, 2026 — Lack of Assurance of Sterility (SCOPE HEALTH) · FDA recall D-0499-2026
Class II · Mar 25, 2026 — Lack of Assurance of Sterility (Preferred Pharmaceuticals, Inc.) · FDA recall D-0443-2026
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0411-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59779-109-50
Product NDC 59779-109
11-digit billing NDC 59779010950
RxCUI 104155
UNII PDC6A3C0OX
UPC 0050428619445
Application # M007
SPL Set ID c92ca67b-bea2-4be0-95ab-15f9b55568c1
Established class (EPC) Non-Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-09-18
Route RECTAL
Dosage form SUPPOSITORY
Substance GLYCERIN
Quick answers
  • RxCUI (RxNorm): 104155
Why two NDCs? The FDA registers this code as 59779-109-50 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59779-0109-50. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen
Drug family (ATC) Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is a rectal suppository containing glycerin, marketed as an OTC monograph laxative product. Glycerin is a hygroscopic agent that is typically used to relieve occasional constipation by drawing water into the bowel and softening stool. The suppository form is designed for rectal insertion to provide localized effect. This product is available over the counter without a prescription.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 25 suppositories 100 suppositories
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
59779-0109-50 You're viewing this 50 SUPPOSITORY in 1 JAR 2014-09-18 — Active
59779-0109-25 59779-109-25 25 SUPPOSITORY in 1 JAR 2014-09-18 — Active
59779-0109-00 59779-109-00 Main listing 100 SUPPOSITORY in 1 JAR 2014-09-18 — Active

You're viewing one of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 50 suppositories — 50 suppository in 1 jar.
How does this package differ from NDC 59779-0109-25?
Both are CVS Pharmacy Glycerin Laxative 2 g Suppository — the drug itself is identical. This page's package is the 50 suppositories one, while NDC 59779-0109-25 is the 25 suppositories package.
What NDC number is used to bill for this package of CVS Pharmacy Glycerin Laxative 2 g Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Glycerin 2 g 70000-0572-01 Cardinal 25 suppositories $0.103 — Availability likely —
Glycerin 2 g 57237-0325-21 Rising 12 suppositories $0.217 — Availability likely —
Proctozone GMax 2 g 57237-0339-21 Rising 12 suppositories $0.217 — Availability likely —
Fleet 2 g 00132-0075-00 C.B. 100 suppositories — — FDA listed —
Walgreens Adult Glycerin Laxative 2 g 00363-0445-25 Walgreens 62.5 g — — FDA listed —
Glycerin 2 g 11822-3312-05 Rite 50 suppositories — — FDA listed —
Rite-Aid Glycerin Laxative 2 g 11822-9100-00 RITE 100 suppositories — — FDA listed —
Glycerin Laxative 2 g 13709-0322-01 NeilMed 25 capsules — — FDA listed —
Glycerin Laxative 2 g/2.5g 13709-0329-01 Neilmed 2.5 g — — FDA listed —
Glycerin 2 g 37808-0398-50 H 50 suppositories — — FDA listed —
Stratuscare Adult Glycerin 2 g 58980-0410-12 Stratus 12 suppositories — — FDA listed —
CVS Pharmacy Glycerin Laxative 2 gthis 59779-0109-50 CVS 50 suppositories — — FDA listed —
Glycerin 2 g 68016-0015-79 Chain 25 suppositories — — FDA listed —
Glycerin 2 g 69842-0724-10 CVS 100 suppositories — — FDA listed —
Bliss GVS 2 g 72701-0106-05 Bliss 100 suppositories — — FDA listed —
Glycerin 2 g 84415-0039-50 Everpharm 50 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Sep 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeBullet
Size32 mm
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

3 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statespurified water, sodium hydroxide, stearic acid

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCVS Pharmacy
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code59779
First marketedSep 2014
Product typeHuman Otc Drug
Portfolio551 products on file

More NDCs from CVS Pharmacy labeler code 59779

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 18 words ▾

Do not use Do not use laxative products for longer than 1 week unless directed by a doctor

⏱️ Dosage and Administration 55 words ▾

Directions adults and children 6 years and over 1 suppository per day or as directed by doctor children 2 to under 6 years use CVS/pharmacy(TM) Child Suppositories children under 2 years ask a doctor insert 1 suppository well up into the rectum and retain fo 15 minutes it need not melt to produce laxative action

⚠️ Warnings 5 words ▾

Warnings For rectal use only

🧪 Active Ingredient 13 words ▾

Active Ingredient Active Ingredient Purpose (in each suppository) Glycerin, USP 2 grams ............................................Laxative

🧪 Inactive Ingredients 8 words ▾

Inactive ingredients purified water, sodium hydroxide, stearic acid

🎯 Purpose 14 words ▾

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 1/4 to 1 hour

📄 Ask a Doctor Before Use If 36 words ▾

Ask a doctor before use if you have Ask a doctor before use if you have - abdominal pain - nausea - vomiting - noticed a sudden change in bowel habits that lasts over 2 weeks

📄 Ask a Doctor or Pharmacist Before Use If 38 words ▾

Stop use and ask a doctor if Stop use and ask a doctor if -you have rectal bleeding -you fail to have a bowel movement after use of a laxative These could be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 14 words ▾

If pregnant or breast-feeding, If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 26 words ▾

When using this product When using this product you may have rectal discomfort or a burning sensation

Other information keep tightly closed - avoid excessive heat

📄 Package Label / Principal Display Panel 4 words ▾

Product Label Product Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by CVS Pharmacy. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 25 suppositories (59779-0109-25), 100 suppositories (59779-0109-00). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
CVS Pharmacy is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 59779-0107-09 · CVS 59779-0112-08 · CVS →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.